Equine neutrophil antimicrobial peptide 2 (eNAP-2), a recently described antimicrobial peptide isolated from equine neutrophils, was found to selectively inactivate microbial serine proteases (subtilisin A and proteinase K) without inhibiting mammalian serine proteases (human neutrophil elastase, human cathepsin G, and bovine pancreatic trypsin). Although the primary structure of eNAP-2 resembled that of several known antiproteases that belong to the 4-disulfide core peptide family, this pattern of selectivity is unique. eNAP-2 formed a noncovalent complex with native subtilisin A or proteinase K but did not associate with these enzymes if they had been treated with phenylmethylsulfonyl fluoride, a serine protease inhibitor. The eNAP-2-microbial protease complex was disrupted by boiling or by exposure to low pH. We suggest that eNAP-2 exerted selective antiproteinase activity by binding tightly but noncovalently to the active site of subtilisin A or proteinase K.
Since microbial exoproteases may act as virulence factors, the combined antimicrobial and antiprotease activities of eNAP-2 could allow it to play an important role in neutrophil-mediated antimicrobial defenses.
Neutrophils, the most abundant phagocytes in blood, contain a variety of antimicrobial peptides and proteins that equip them to kill ingested microorganisms. We recently purified a novel peptide, equine neutrophil antimicrobial peptide 2 (eNAP-2), from acid-extracted equine neutrophil granules and described both its antibiotic properties and N-terminal sequence (1) . Its structural homology to the 4-disulfide core family, some of whose members are antiproteases, led us to test the ability of eNAP-2 to inhibit serine proteases. We found that eNAP-2 was a potent and selective inhibitor of the microbial serine proteases subtilisin A and proteinase K.
MATERIALS AND METHODS eNAP-2. eNAP-2 was purified from equine blood or from sterile uterine exudates as described previously (1, 2) . Briefly, peripheral blood neutrophils (polymorphonuclear leukocytes) were isolated on a discontinuous Percoll density gradient and disrupted by nitrogen cavitation; disruption was followed by low-speed centrifugation, which yielded a granule-rich postnuclear supernatant. The cytoplasmic granules were recovered by centrifugation at 27,000 x g for 20 min at 2°C, extracted in ice-cold 10% acetic acid, and concentrated by vacuum centrifugation. eNAP-2 that had been purified to apparent homogeneity by gel permeation and reversed-phase high performance liquid chromatography (2) was lyophilized and redissolved in 0.01% acetic acid for use in these studies. Human and rabbit defensin peptides used as controls in these experiments had been previously isolated and purified in our laboratory (4, 16 Antiprotease selectivity. Preincubation of eNAP-2 with the tubes, and assessed for endopeptidase activity by using a microbial proteinase subtilisin A or proteinase K abolished modification of a previously described technique (14) .
both the amidase and endopeptidase activities of these Briefly, after the enzyme, enzyme-inhibitor complex, or enzymes ( Fig. 1) . In contrast, preincubation of a fourfold enzyme-control mixture had been incubated with the submolar excess of eNAP-2 with several serine proteases of strate, aliquots of the mixture were removed, mixed with mammalian origin, including human neutrophil elastase, 10% trichloroacetic acid (Sigma), and centrifuged at 8,000 x human cathepsin G, and bovine pancreatic trypsin, did not g for 3 min, after which the precipitate and supernatant were inhibit their enzymatic activity (data not shown). Preincubaseparated. NaOH (final concentration, 0.5 N) was added to tion of eNAP-2 with microbial proteases for 1 or 3 min the supernatant to enhance color development, and the resulted in suboptimal enzyme inhibition, whereas preincuresulting solution was assessed for A440.
bation for 8 min eliminated enzymatic activity (Fig. 2 ).
Enzyme-inhibitor complex formation. We used several When, instead of being preincubated with the microbial polyacrylamide gel electrophoresis (PAGE) systems (Table protease , eNAP-2 was added 7 min after the enzyme and 2) to characterize the formation of a complex between the substrate were mixed, the inhibitory effects of eNAP-2 microbial proteases and eNAP-2. Denaturing and nondenadeveloped over several minutes, consistent with a slow turing conditions were used for acidic gels (9, 13) and for formation of an enzyme-inhibitor complex (Fig. 3) (Fig. 4) . When, however, such samples were boiled, Hoefer Scientific Instruments, San Francisco, Calif.). The the complex dissociated (data not shown). Development of a approximate stoichiometry of the eNAP-2-enzyme complex stable complex was apparent when PAGE was performed at was determined by incubating a constant amount of eNAP-2 pH 4.3 or 5.7 in the absence of SDS but not when PAGE was with increasing amounts of subtilisin A and proteinase K, up performed at pH 2.5 (data not shown). Although complex to a calculated 2:1 (enzyme/inhibitor) molar ratio. In some formation was complete at a calculated enzyme/inhibitor experiments, identical amounts of these enzymes had been molar ratio of 2:1, the substantial autodegradation of the exposed to 1 mM phenylmethylsulfonyl fluoride (PMSF), a proteases (see below) suggested that the actual stoichiomeserine protease inhibitor, prior to incubation with eNAP-2.
try of the complex between intact enzyme and eNAP-2 was more probably 1:1. When analyzed by SDS-Tricine-PAGE without prior treatment with PMSF, both subtilisin A and proteinase K underwent marked spontaneous autolysis (Fig.  4, lanes 5 and 11) . It has been shown that SDS can increase the activity of proteinase K as much as sevenfold over the activity exhibited in the absence of SDS (8) . No significant protease autodegradation was observed after subtilisin A and proteinase K bound to eNAP-2, and, as expected, preincubation with PMSF also protected both proteases from autodegradation (lanes 6 and 12). Pretreatment of the proteases with PMSF completely prevented the subsequent formation of a complex with eNAP-2 (data not shown). All of these observations suggest that the active-site serine participated in the eNAP-2-protease interaction. 
DISCUSSION
The presence in equine neutrophils of cationic peptides that selectively inhibited the activity of subtilisin A and proteinase K was previously reported by Pellegrini et al. (10) . Although no information was provided about the amino acid sequence or antimicrobial activity of these peptides, their Mr was reported to range between 6,300 and 7,400.
eNAP-2, a cationic peptide whose Mr is approximately 6,500, fits this general description perfectly (1) .
Two constellations of serine proteases have been described: the subtilisin and chymotrypsin superfamilies (7) . Whereas the subtilisin superfamily, whose members include 1.6 |~~~~~~Control| t 1.8 Exoproteases reportedly act as virulence factors for a variety of microorganisms including Legionella pneumophila, Pseudomonas aeruginosa, and Candida albicans (3, 5, 12) . Not only may some microbial proteases damage host tissues directly, but also others may cause damage indirectly by activating endogenous interstitial procollagenases in fibroblasts and neutrophils (17) .
Since eNAP-2 and the microbial proteases formed a stable complex over a wide range of conditions of pH, osmolarity, and temperature, they are also likely to do so in vivo. Because eNAP-2 exists at a moderately high concentration within the cytoplasmic granules of equine neutrophils (1), its secretion into phagolysosomes or its extracellular release could defend these compartments from the effects of unopposed microbial proteases. The dual antimicrobial and antiprotease activities of eNAP-2 may allow it to play an important role in equine host defense against infection.
